Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 188

The DOI matches its Crossref record.

Melatonin Fails to Improve Sleep or Agitation in Double-Blind Randomized Placebo-Controlled Trial of Institutionalized Patients With Alzheimer Disease

Open access
Gehrman, Philip R., Connor, Donald J., Martin, Jennifer L., Shochat, Tamar, Corey-Bloom, Jody, Ancoli-Israel, Sonia · 2009 · The American Journal of Geriatric Psychiatry

Abstract

Objectives Patients with Alzheimer’s dementia often display both agitated behavior and poor sleep. Given that the disease is often associated with low endogenous levels of melatonin, exogenous melatonin administration may lead to improvements in sleep and agitation. Design Randomized, placebo-controlled study. Setting Nursing homes in San Diego metropolitan area. Participants Subjects were patients with probable Alzheimer’s disease. Intervention Melatonin (8.5 mg immediate release and 1.5 mg sustained release) (n=24) or placebo (n=17) administered at 10:00 PM for 10 consecutive nights. The protocol consisted of baseline (3 days), treatment (10 days), and post-treatment (5 days) phases. Measurements Sleep was measured continuously using actigraphy. Agitation was rated using both the Agitated Behavior Rating Scale and the Cohen-Mansfield Agitation Inventory. Treatment effects were examined both across the 24-hour day and separately by nursing shift. Results There were no significant effects of melatonin, compared to placebo, on sleep, circadian rhythms, or agitation. Conclusion This study failed to find a beneficial effect of exogenous melatonin, consistent with a number of other studies. The lack of efficacy may be related to the absence of a true treatment effect or to the super-physiological dose of melatonin used.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/jgp.0b013e318187de18

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 188

Metadata

Authors
Gehrman, P. R., Connor, D. J., Martin, J. L., Shochat, T., Corey-Bloom, J., & Ancoli-Israel, S.
Venue
The American Journal of Geriatric Psychiatry
Publisher
Elsevier BV
Published
2009-02
Volume
17
Issue
2
Pages
166-169
ISSN
1064-7481 (ISSN-L)
OpenAlex
W2064425811
Cited by
188
References
0
FWCI
5.88
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melatonin Fails to Improve Sleep or Agitation in Double-Blind Randomized Placebo-Controlled Trial of Institutionalized Patients With Alzheimer Disease. https://app.cochat.ai/papers/10.1097/jgp.0b013e318187de18
The paper
Gehrman, P. R., Connor, D. J., Martin, J. L., Shochat, T., Corey-Bloom, J., & Ancoli-Israel, S. (2009). Melatonin Fails to Improve Sleep or Agitation in Double-Blind Randomized Placebo-Controlled Trial of Institutionalized Patients With Alzheimer Disease. The American Journal of Geriatric Psychiatry. https://doi.org/10.1097/jgp.0b013e318187de18

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.